We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




POC 3D Imaging Platform Enables Real-Time Assessment of Surgical Specimens in OR

By HospiMedica International staff writers
Posted on 06 Oct 2023

Lumpectomies often come with the risk of re-excisions, or additional surgeries, which not only affect the patient's healing and appearance but also result in a higher financial burden. More...

Now, a high-resolution 3D specimen imaging system uses an advanced reconstruction algorithm to offer real-time detailed surgical information to clinicians treating breast cancer, promising to cut down on re-excisions in breast-conserving surgery.

Clarix Imaging’s (Chicago, IL, USA) VSI-360 volumetric specimen imaging system is a state-of-the-art, point-of-care 3D imaging platform that provides real-time evaluation of surgical samples right inside the operating room. The FDA-cleared volumetric specimen imager is Clarix Imaging’s first flagship product and provides unparalleled clarity in visualizing intraoperative specimen margin during breast cancer surgeries like lumpectomies. With its precise technology and workflow-centric software, VSI-360 allows surgeons and radiologists to generate an accurate 3D model of the specimen and view the tumor in thin image slices, preventing overlapping tissues from obscuring the margins.

Clarix Imaging’s groundbreaking innovation is based on its proprietary image reconstruction technology which enables high-quality, isotropic imaging in a considerably shorter scan time. This leap in technology has allowed Clarix to develop a portable system that fits seamlessly into the busy workflow of an operating room, enabling quick confirmation that the correct tissue has been removed, thereby streamlining the surgical process. Clarix Imaging’s expertise in volumetric imaging, coupled with its expanding collection of 3D images of breast cancer, has the potential to open up new avenues for clinical research and applications, particularly with the integration of artificial intelligence, ultimately raising the standard of patient care.

Related Links:
Clarix Imaging


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Critical Care Cart
Avalo
New
Pocket Fetal Doppler
CONTEC10C/CL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.